Annual D&A
$8.86 M
-$4.32 M-32.77%
26 May 2024
Summary:
Lifecore Biomedical annual depreciation & amortization is currently $8.86 million, with the most recent change of -$4.32 million (-32.77%) on 26 May 2024. During the last 3 years, it has fallen by -$11.01 million (-55.41%). LFCR annual D&A is now -55.41% below its all-time high of $19.87 million, reached on 31 May 2021.LFCR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$2.04 M
+$51.00 K+2.56%
24 November 2024
Summary:
Lifecore Biomedical quarterly depreciation & amortization is currently $2.04 million, with the most recent change of +$51.00 thousand (+2.56%) on 24 November 2024. Over the past year, it has increased by +$278.00 thousand (+15.74%). LFCR quarterly D&A is now -65.39% below its all-time high of $5.91 million, reached on 01 November 2021.LFCR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$8.96 M
+$278.00 K+3.20%
24 November 2024
Summary:
Lifecore Biomedical TTM depreciation & amortization is currently $8.96 million, with the most recent change of +$278.00 thousand (+3.20%) on 24 November 2024. Over the past year, it has dropped by -$855.00 thousand (-8.71%). LFCR TTM D&A is now -57.32% below its all-time high of $21.00 million, reached on 01 November 2021.LFCR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LFCR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.8% | +15.7% | -8.7% |
| 3 y3 years | -55.4% | -65.4% | -57.3% |
| 5 y5 years | -41.8% | -54.9% | -49.7% |
LFCR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -55.4% | at low | -65.4% | +15.7% | -57.3% | +3.2% |
| 5 y | 5 years | -55.4% | at low | -65.4% | +15.7% | -57.3% | +3.2% |
| alltime | all time | -55.4% | +1671.8% | -65.4% | +937.7% | -57.3% | +8862.0% |
Lifecore Biomedical Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | - | $2.04 M(+2.6%) | $8.96 M(+3.2%) |
| Aug 2024 | - | $1.99 M(-11.5%) | $8.68 M(-2.0%) |
| May 2024 | $8.86 M(-32.8%) | $2.25 M(-15.8%) | $8.86 M(-4.5%) |
| Feb 2024 | - | $2.67 M(+51.4%) | $9.28 M(-5.5%) |
| Nov 2023 | - | $1.77 M(-18.5%) | $9.82 M(-10.7%) |
| Aug 2023 | - | $2.17 M(-18.8%) | $10.99 M(-16.6%) |
| May 2023 | $13.18 M(-27.0%) | $2.67 M(-16.9%) | $13.18 M(-6.4%) |
| Feb 2023 | - | $3.21 M(+9.3%) | $14.08 M(-2.2%) |
| Nov 2022 | - | $2.94 M(-32.5%) | $14.40 M(-17.1%) |
| Aug 2022 | - | $4.35 M(+21.9%) | $17.36 M(-3.9%) |
| May 2022 | $18.06 M(-9.1%) | $3.57 M(+1.2%) | $18.06 M(-7.6%) |
| Feb 2022 | - | $3.53 M(-40.2%) | $19.55 M(-6.9%) |
| Nov 2021 | - | $5.91 M(+16.8%) | $21.00 M(+6.0%) |
| Aug 2021 | - | $5.05 M(-0.1%) | $19.82 M(-0.2%) |
| May 2021 | $19.87 M(+5.5%) | - | - |
| May 2021 | - | $5.06 M(+1.5%) | $19.87 M(+0.1%) |
| Feb 2021 | - | $4.98 M(+5.5%) | $19.85 M(+1.1%) |
| Nov 2020 | - | $4.72 M(-7.4%) | $19.63 M(+1.0%) |
| Aug 2020 | - | $5.10 M(+1.3%) | $19.44 M(+3.2%) |
| May 2020 | $18.84 M(+23.7%) | $5.04 M(+5.6%) | $18.84 M(+1.7%) |
| Feb 2020 | - | $4.77 M(+5.4%) | $18.52 M(+4.1%) |
| Nov 2019 | - | $4.53 M(+0.5%) | $17.80 M(+7.3%) |
| Aug 2019 | - | $4.50 M(-4.7%) | $16.59 M(+8.9%) |
| May 2019 | $15.23 M(+22.7%) | $4.72 M(+16.7%) | $15.23 M(+10.0%) |
| Feb 2019 | - | $4.05 M(+22.2%) | $13.84 M(+7.0%) |
| Nov 2018 | - | $3.31 M(+5.3%) | $12.94 M(+2.6%) |
| Aug 2018 | - | $3.15 M(-5.7%) | $12.60 M(+1.5%) |
| May 2018 | $12.41 M(+16.2%) | $3.34 M(+6.2%) | $12.41 M(+4.1%) |
| Feb 2018 | - | $3.14 M(+5.4%) | $11.93 M(+3.7%) |
| Nov 2017 | - | $2.98 M(+0.9%) | $11.50 M(+3.8%) |
| Aug 2017 | - | $2.95 M(+3.6%) | $11.08 M(+3.8%) |
| May 2017 | $10.68 M(+13.6%) | $2.85 M(+4.9%) | $10.68 M(-0.5%) |
| Feb 2017 | - | $2.72 M(+6.1%) | $10.74 M(+5.6%) |
| Nov 2016 | - | $2.56 M(+0.4%) | $10.17 M(+4.4%) |
| Aug 2016 | - | $2.55 M(-12.3%) | $9.73 M(+3.6%) |
| May 2016 | $9.39 M(+32.5%) | $2.91 M(+35.5%) | $9.39 M(+11.9%) |
| Feb 2016 | - | $2.15 M(+0.9%) | $8.40 M(+3.9%) |
| Nov 2015 | - | $2.13 M(-3.8%) | $8.09 M(+3.8%) |
| Aug 2015 | - | $2.21 M(+15.6%) | $7.79 M(+9.8%) |
| May 2015 | $7.09 M(-0.3%) | $1.91 M(+4.3%) | $7.09 M(+2.4%) |
| Feb 2015 | - | $1.83 M(+0.2%) | $6.93 M(+3.9%) |
| Nov 2014 | - | $1.83 M(+21.0%) | $6.67 M(-1.7%) |
| Aug 2014 | - | $1.51 M(-13.5%) | $6.79 M(-4.6%) |
| May 2014 | $7.11 M(-2.5%) | $1.75 M(+11.0%) | $7.11 M(-0.3%) |
| Feb 2014 | - | $1.58 M(-18.9%) | $7.13 M(-3.9%) |
| Nov 2013 | - | $1.95 M(+5.6%) | $7.42 M(+1.9%) |
| Aug 2013 | - | $1.84 M(+4.2%) | $7.28 M(-0.2%) |
| May 2013 | $7.29 M(+29.8%) | $1.77 M(-5.3%) | $7.29 M(+3.7%) |
| Feb 2013 | - | $1.87 M(+3.4%) | $7.04 M(+7.4%) |
| Nov 2012 | - | $1.80 M(-2.7%) | $6.55 M(+7.0%) |
| Aug 2012 | - | $1.86 M(+22.9%) | $6.12 M(+8.9%) |
| May 2012 | $5.62 M(+5.8%) | $1.51 M(+9.3%) | $5.62 M(+1.9%) |
| Feb 2012 | - | $1.38 M(+0.6%) | $5.51 M(+1.4%) |
| Nov 2011 | - | $1.37 M(+1.4%) | $5.44 M(+1.5%) |
| Aug 2011 | - | $1.35 M(-3.4%) | $5.36 M(+0.9%) |
| May 2011 | $5.31 M | $1.40 M(+7.3%) | $5.31 M(+8.8%) |
| Feb 2011 | - | $1.31 M(+0.9%) | $4.88 M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | $1.30 M(-0.8%) | $4.42 M(+13.2%) |
| Aug 2010 | - | $1.31 M(+34.2%) | $3.91 M(+16.2%) |
| May 2010 | $3.36 M(+7.2%) | $973.00 K(+14.5%) | $3.36 M(+7.3%) |
| Feb 2010 | - | $850.00 K(+9.1%) | $3.14 M(+2.3%) |
| Nov 2009 | - | $779.00 K(+2.2%) | $3.06 M(-1.3%) |
| Aug 2009 | - | $762.00 K(+2.3%) | $3.10 M(-1.1%) |
| May 2009 | $3.14 M(-2.0%) | $745.00 K(-4.4%) | $3.14 M(-5.6%) |
| Feb 2009 | - | $779.00 K(-4.9%) | $3.33 M(-0.7%) |
| Nov 2008 | - | $819.00 K(+2.9%) | $3.35 M(+2.0%) |
| Aug 2008 | - | $796.00 K(-14.5%) | $3.28 M(+2.5%) |
| May 2008 | $3.20 M(-1.7%) | $931.00 K(+15.8%) | $3.20 M(+7.1%) |
| Feb 2008 | - | $804.00 K(+6.8%) | $2.99 M(+0.9%) |
| Nov 2007 | - | $753.00 K(+5.2%) | $2.96 M(-4.1%) |
| Aug 2007 | - | $716.00 K(-0.3%) | $3.09 M(-5.2%) |
| May 2007 | $3.26 M(+1.8%) | $718.00 K(-7.5%) | $3.26 M(-4.4%) |
| Feb 2007 | - | $776.00 K(-11.8%) | $3.41 M(-0.9%) |
| Nov 2006 | - | $880.00 K(-0.7%) | $3.44 M(+3.5%) |
| Aug 2006 | - | $886.00 K(+2.2%) | $3.32 M(+3.7%) |
| May 2006 | $3.20 M(-7.6%) | $867.00 K(+7.4%) | $3.20 M(+4.0%) |
| Feb 2006 | - | $807.00 K(+5.8%) | $3.08 M(-6.5%) |
| Nov 2005 | - | $763.00 K(-0.4%) | $3.29 M(-2.9%) |
| Aug 2005 | - | $766.00 K(+3.0%) | $3.39 M(-2.2%) |
| May 2005 | $3.47 M(-6.4%) | $744.00 K(-27.1%) | $3.47 M(-7.3%) |
| Feb 2005 | - | $1.02 M(+18.5%) | $3.74 M(+2.3%) |
| Nov 2004 | - | $861.00 K(+2.3%) | $3.65 M(-0.2%) |
| Aug 2004 | - | $842.00 K(-17.1%) | $3.66 M(-1.2%) |
| May 2004 | $3.71 M(+81.5%) | $1.02 M(+8.5%) | $3.71 M(+3.2%) |
| Feb 2004 | - | $936.00 K(+8.0%) | $3.59 M(+1.6%) |
| Nov 2003 | - | $867.00 K(-2.1%) | $3.53 M(-2.9%) |
| Aug 2003 | - | $886.00 K(-1.6%) | $3.64 M(-0.9%) |
| May 2003 | $2.04 M(-41.7%) | - | - |
| Apr 2003 | - | $900.00 K(+2.4%) | $3.67 M(+0.9%) |
| Jan 2003 | - | $879.00 K(-9.6%) | $3.64 M(+3.9%) |
| Oct 2002 | $3.50 M(-35.5%) | $972.00 K(+5.7%) | $3.50 M(-12.3%) |
| July 2002 | - | $920.00 K(+6.1%) | $3.99 M(+2.3%) |
| Apr 2002 | - | $867.00 K(+17.0%) | $3.90 M(-20.2%) |
| Jan 2002 | - | $741.00 K(-49.3%) | $4.88 M(-10.1%) |
| Oct 2001 | $5.43 M(+6.2%) | $1.46 M(+76.4%) | $5.43 M(+12.4%) |
| July 2001 | - | $829.00 K(-55.2%) | $4.83 M(-13.0%) |
| Apr 2001 | - | $1.85 M(+43.7%) | $5.55 M(+6.7%) |
| Jan 2001 | - | $1.29 M(+49.6%) | $5.20 M(+1.7%) |
| Oct 2000 | $5.11 M(+251.2%) | $861.00 K(-44.5%) | $5.11 M(+27.6%) |
| July 2000 | - | $1.55 M(+3.4%) | $4.01 M(+31.1%) |
| Apr 2000 | - | $1.50 M(+25.1%) | $3.06 M(+41.8%) |
| Jan 2000 | - | $1.20 M(-591.8%) | $2.16 M(+48.1%) |
| Oct 1999 | $1.46 M(-30.7%) | -$244.00 K(-140.7%) | $1.46 M(-33.8%) |
| July 1999 | - | $600.00 K(0.0%) | $2.20 M(0.0%) |
| Apr 1999 | - | $600.00 K(+20.0%) | $2.20 M(+4.8%) |
| Jan 1999 | - | $500.00 K(0.0%) | $2.10 M(0.0%) |
| Oct 1998 | $2.10 M(+90.9%) | $500.00 K(-16.7%) | $2.10 M(+5.0%) |
| July 1998 | - | $600.00 K(+20.0%) | $2.00 M(+11.1%) |
| Apr 1998 | - | $500.00 K(0.0%) | $1.80 M(+20.0%) |
| Jan 1998 | - | $500.00 K(+25.0%) | $1.50 M(+36.4%) |
| Oct 1997 | $1.10 M(+120.0%) | $400.00 K(0.0%) | $1.10 M(+57.1%) |
| July 1997 | - | $400.00 K(+100.0%) | $700.00 K(+133.3%) |
| Apr 1997 | - | $200.00 K(+100.0%) | $300.00 K(+200.0%) |
| Jan 1997 | - | $100.00 K | $100.00 K |
| Oct 1996 | $500.00 K | - | - |
FAQ
- What is Lifecore Biomedical annual depreciation & amortization?
- What is the all time high annual D&A for Lifecore Biomedical?
- What is Lifecore Biomedical annual D&A year-on-year change?
- What is Lifecore Biomedical quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly D&A year-on-year change?
- What is Lifecore Biomedical TTM depreciation & amortization?
- What is the all time high TTM D&A for Lifecore Biomedical?
- What is Lifecore Biomedical TTM D&A year-on-year change?
What is Lifecore Biomedical annual depreciation & amortization?
The current annual D&A of LFCR is $8.86 M
What is the all time high annual D&A for Lifecore Biomedical?
Lifecore Biomedical all-time high annual depreciation & amortization is $19.87 M
What is Lifecore Biomedical annual D&A year-on-year change?
Over the past year, LFCR annual depreciation & amortization has changed by -$4.32 M (-32.77%)
What is Lifecore Biomedical quarterly depreciation & amortization?
The current quarterly D&A of LFCR is $2.04 M
What is the all time high quarterly D&A for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly depreciation & amortization is $5.91 M
What is Lifecore Biomedical quarterly D&A year-on-year change?
Over the past year, LFCR quarterly depreciation & amortization has changed by +$278.00 K (+15.74%)
What is Lifecore Biomedical TTM depreciation & amortization?
The current TTM D&A of LFCR is $8.96 M
What is the all time high TTM D&A for Lifecore Biomedical?
Lifecore Biomedical all-time high TTM depreciation & amortization is $21.00 M
What is Lifecore Biomedical TTM D&A year-on-year change?
Over the past year, LFCR TTM depreciation & amortization has changed by -$855.00 K (-8.71%)